1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Sample preparation approach influences pam50 risk of recurrence score in early breast cancer
(
- Contribution to journal › Article
- 2019
-
Mark
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
(
- Contribution to journal › Article
- 2016
-
Mark
Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer
(
- Contribution to journal › Article